Insiders who reported open-market trades in the last 12 months at the companies Tasos Konidaris files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Nikita Shah - $4.14M in AMRX purchases and sales in the last 12 months
Jason B. Daly - $3.77M in AMRX purchases and sales in the last 12 months
John Kiely - $882K in AMRX purchases and sales in the last 12 months
Ted C. Nark - $586K in AMRX purchases and sales in the last 12 months
Deborah M. Autor - $451K in AMRX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Tasos Konidaris is a corporate insider, tracked as Executive Vice President & CFO of Amneal Pharmaceuticals, Inc. (AMRX). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Tasos Konidaris last file a Form 4?
The most recent primary Form 4 on record is dated 5 March 2026, one of 3 filings going back to 2025.
Has Tasos Konidaris been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($4.66M) across all tracked filings.
Tasos Konidaris is Executive Vice President & CFO of Amneal Pharmaceuticals, Inc. (AMRX). 3 SEC Form 4 filings on record going back to 2025, most recently on 5 March 2026. Most recent open-market trade: sold $2.07M of AMRX on 13 August 2025. Lifetime open-market sales: $4.66M.
Recent transactions
13
The latest 13 SEC Form 4 transactions reported by Tasos Konidaris.
InsiderAlpha's records for Tasos Konidaris go back to 2025: 3 primary Form 4 filings, an average of 1.5 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
